Two preventive tools — a maternal vaccine and a monoclonal antibody — were tied to a recent drop in RSV hospitalization rates for U.S. babies.

As winter nears and the cold and flu season sets in, the highly infectious respiratory virus RSV has again begun its spread. So far this year, the National Disease Surveillance System (NDSS ...

GSK has claimed a new approval for its respiratory syncytial virus (RSV) vaccine Arexvy, currently locked in a battle for market share with rival shots from Pfizer and Moderna, that could lend it ...

New phase 2b/3 trial results with MSD's experimental respiratory syncytial virus (RSV) antibody clesrovimab have fired a shot across the bows of AstraZeneca and Sanofi, currently predicting ...

A new wave of talent, led by Strings, Molly Tuttle, Zach Top and others, are redefining a once-niche genre for a whole generation. By Steve Knopper Susto frontman Justin Osborne did not record ...

Several studies have previously warned over the risks of emulsifiers and colon cancer, with doctors even saying they might break down the protective layer of mucus lining the gut — allowing ...

Other common symptoms include feeling that too much mucus is collecting in the throat and excessive burping. Exactly what that cup of coffee does inside your body minute by minute (and yes ...

Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...

For these reasons, it is the most widely used diagnostic test for RSV. RADTs are rapid immunoassays and are available from a variety of manufacturers in ready-made commercialized kits. With one ...

Far North residents have been fascinated by a strange, stringy substance that has been floating around recently. Photo / Boyce Lawrence A strange, stringy substance floating through the air and ...

For his bronze, The Nawi, Bidjigal elder Uncle Steven Russell cut the hull from a specially selected stringy bark tree.

Infant hospitalization rates for respiratory syncytial virus (RSV) were 28% to 43% lower in 2024-25, the first US respiratory-virus season with broad availability of a maternal RSV vaccine (Abrysvo) ...